MEFV Gene Mutations May Not Affect Drug-Resistant Epilepsy in Kids
This study looked at the MEFV gene and its possible connection to drug-resistant epilepsy (DRE) in children.
This hub covers drug-resistant epilepsy: When seizures aren’t controlled after trying two appropriate medicines. Research-backed next steps on diet therapies, devices, surgery evaluation, and safety.
If seizures aren’t controlled after two meds, it’s worth at least an evaluation at an epilepsy center.
Not necessarily. Some familiar consider it earlier depending on seizure type and goals.
Yes. Treatment response can change over time, and combinations/approaches matter.
Seizure frequency, triggers, sleep, missed meds, side effects, and rescue med use.
This study looked at the MEFV gene and its possible connection to drug-resistant epilepsy (DRE) in children.
Researchers studied different brain imaging techniques to find out which ones are best at locating the exact spot in the brain where seizures start in people with epilepsy who do not respond to medication.
A recent study looked at how effective and safe different dietary treatments are for people with drug-resistant epilepsy, which means their seizures do not respond well to medications.
Researchers studied the use of cannabidiol (CBD) as an additional treatment for children over the age of 2 who have drug-resistant epileptic spasms (ES).
Researchers studied the use of nicotine as a treatment for Sleep-Related Hypermotor Epilepsy (SHE), a type of epilepsy that can have a genetic cause.
In this study, researchers looked at how sevoflurane anesthesia affects brain activity in children with drug-resistant focal epilepsy.
This study looked at the effects of a plant extract called Ammi visnaga, commonly known as the toothpick plant, on seizures in mice.
This study looked at pediatric epilepsy in Palestine, focusing on children aged 2 months to 18 years who were diagnosed between 2019 and 2024.
A study was conducted to evaluate the effectiveness and safety of a new medication called JNJ-40411813 when used alongside two existing epilepsy treatments, levetiracetam and brivaracetam.